• Dihydrotestosterone (DHT) Assay Guide

  2026-09-02

  This scenario-based guide explains how Dihydrotestosterone (DHT), SKU B8214, can support reproducible androgen receptor, proliferation, viability, and signaling experiments. It covers solvent compatibility, dose selection, interpretation of EGFR, ERBB2, AKT, and ERK readouts, cross-model limitations, and practical product-selection criteria.

• Naftifine HCl for Reproducible Cell Assays

  2026-09-02

  Learn how Naftifine HCl, SKU B1984, can support controlled antifungal and cell-assay workflows through defined solubility, high purity, and documented HPLC/NMR quality control. This scenario-based guide separates fungal mechanism studies from mammalian viability interpretation and provides practical preparation and comparison criteria.

• DNase I (RNase-free) for Clean RNA Workflows

  2026-09-01

  Discover how DNase I (RNase-free) improves RNA extraction, RT-PCR, and transcription workflows while protecting biological interpretation. This guide connects DNA cleanup decisions with mechanistic cancer research on CAF-derived lactate, ANTXR1 lactylation, and oxaliplatin resistance.

• Latrunculin B for Reliable Actin Assays

  2026-09-01

  Learn how Latrunculin B (SKU C5804) can clarify actin-dependent effects in viability, proliferation, cytotoxicity, and viral-entry workflows. This scenario-based guide covers mechanism, controls, handling, interpretation, and practical supplier selection using product specifications and published evidence.

• GANT61 in ALK-Positive ALCL: Hh–PI3K/Akt Mechanism

  2026-08-31

  A 2026 study identifies a potential Hh–PIK3IP1–Akt signaling connection through which GANT61 suppresses ALK-positive anaplastic large cell lymphoma growth. Its combined proliferation, flow cytometry, transcriptomic, and molecular analyses link Gli1 inhibition with cell-cycle arrest and apoptosis, while also defining important validation steps for future work.

• Latrunculin A for Mechanobiology Assays

  2026-08-31

  Use Latrunculin A to separate stiffness sensing from actin-dependent growth-cone remodeling in DRG neuron experiments. This workflow combines rapid, reversible cytoskeleton perturbation with quantitative imaging, making it useful for mechanobiology, migration, and morphology assays.

• Bismuth Subsalicylate in GI and Cell Assays

  2026-08-30

  Bismuth Subsalicylate supports gastrointestinal disorder research while offering a practical platform for studying inflammation pathway modulation and membrane changes. This workflow pairs careful handling of an insoluble bismuth salt with recombinant annexin V assays to separate pathway effects from nonspecific cellular injury.

• DNase I (RNase-free) for Translational RNA Fidelity

  2026-08-29

  A thought-leadership guide to using DNase I (RNase-free) as a data-quality control in RNA extraction, RT-PCR, in vitro transcription, and tumor-microenvironment research. The article connects DNA-removal strategy with mechanistic studies of CAF-derived lactate, ANTXR1 lactylation, cancer stemness, and oxaliplatin resistance while distinguishing established evidence from workflow recommendations.

• T0070907: A Precision PPARγ Antagonist

  2026-08-28

  T0070907 is a covalent, high-affinity PPARγ antagonist for separating receptor-dependent transcription from downstream cellular effects. Use it to interrogate adipogenesis, RXRα/PPARγ pathway activity, macrophage inflammation, and cancer-associated cell-cycle phenotypes with orthogonal controls.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-08-28

  This 2015 Bioorganic & Medicinal Chemistry Letters study introduced indazole- and indole-based glucagon receptor antagonists derived from the MK-0893 concept. Focused SAR optimization produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity for GRA 16d in humanized glucagon receptor mouse models.

• How CART–RNA Morphology Shapes Delivery

  2026-08-27

  The reference study shows that low-molar-mass Charge-Altering Releasable Transporters (CARTs) form RNA-driven, disordered bicontinuous nanoparticles rather than simple compact polymer aggregates. By combining cryo-electron microscopy, tomography, and small-angle scattering, the work connects polymer chemistry and RNA cargo identity with internal domain spacing and order, providing structural principles for polymer-based RNA delivery.

• GSK-923295: Rethinking CENP-E in Mitosis

  2026-08-27

  GSK-923295 offers a mechanistically defined route to interrogate CENP-E, chromosome alignment, and mitotic fidelity. By placing this small-molecule CENP-E inhibitor alongside emerging evidence on CTCF-dependent centromere architecture, translational researchers can distinguish motor-driven chromosome congression defects from broader centromere maintenance failures.

• LLY-507: Translating SMYD2 Biology

  2026-08-26

  LLY-507 is a selective SMYD2 inhibitor that helps translational researchers connect substrate-specific lysine methylation with cancer cell phenotypes and fibrosis biology. This article examines its mechanism, assay strategy, evidence boundaries, and product-development relevance while distinguishing biochemical potency from cellular pharmacology and clinical readiness.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-26

  Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from ferroptosis by reducing the labile iron pool. The study connects m6A-dependent RNA regulation with post-translational control of lactotransferrin, providing a mechanistic framework for testing iron availability as a determinant of HCC progression and ferroptosis sensitivity.

• JNJ-10198409: A Time-Aware PDGF Inhibitor

  2026-08-25

  JNJ-10198409 is a potent platelet-derived growth factor receptor inhibitor for dissecting PDGF-BB-driven kinase signaling, proliferation, and angiogenesis. This article connects its receptor-proximal pharmacology with a 2025 RSV study to show why signaling timing, phosphorylation state, and orthogonal assay design matter.

8638 records 1/576 page Next 12345 下5页 Last page